Transforming growth factor-β signal transduction

Circulation Research

Volumn 78, Issue 2, 1996, Pages 173-179

  Brand, Thomas ^a   Schneider, Michael D ^b  

^a TECHNICAL UNIVERSITY OF BRAUNSCHWEIG   (Germany)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

growth factors; receptors; signal transduction

Indexed keywords

CYTOKINE; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ANIMAL CELL; CROSS LINKING; DROSOPHILA; GROWTH REGULATION; HEART DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR GENE; RECEPTOR UPREGULATION; SEQUENCE HOMOLOGY; SHORT SURVEY; SIGNAL TRANSDUCTION;

EID: 0029670962     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.78.2.173     Document Type: Short Survey

References (35)

1. Kingsley DM. The TGF-β superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev. 1994;8:133-146.
2. Brand T, Schneider MD. The TGF-β superfamily in myocardium: ligands, receptors, transduction, and function. J Mol Cell Cardiol. 1995;27:5-18.
3. Grainger DJ, Kemp PR, Liu AC, Lawn RM, Metcalfe JC. Activation of transforming growth factor-β is inhibited in transgenic apolipoprotein(a) mice. Nature. 1994;370:460-462.
4. Grainger DJ, Kemp PR, Metcalfe JC, Liu AC, Lawn RM, Williams NR, Grace AA, Schofield PM, Chauhan A. The serum concentration of active transforming growth factor-β is severely depressed in advanced atherosclerosis. Nat Med. 1995;1:74-79.
5. Brand T, Schneider MD. Inactive type II and type I receptors for TGF β are dominant inhibitors of TGF β-dependent transcription. J Biol Chem. 1995;270:8274-8284.
6. Wrana JL, Attisano L, Wieser R, Ventura F, Massague J. Mechanism of activation of the TGF-β receptor. Nature. 1994;370: 341-347.
7. Penton A, Chen YJ, Staehling-Hampton K, Wrana JL, Attisano L, Szidonya J, Cassill JA, Massagué J, Hoffmann FM. Identification of two bone morphogenetic protein type I receptors in Drosophila and evidence that Brk25D is a decapentaplegic receptor. Cell. 1994;78: 239-250.
8. Ventura F, Doody J, Liu F, Wrana JL, Massague J. Reconstitution and transphosphorylation of TGF-β receptor complexes. EMBO J. 1994;13:5581-5589.
9. Yamashita H, ten Dijke P, Franzen P, Miyazono K, Heldin CH. Formation of hetero-oligomeric complexes of type I and type II receptors for transforming growth factor-β. J Biol Chem. 1994;269: 20172-20178.
10. Liu F, Ventura F, Doody J, Massague J. Human type II receptor for bone morphogenic proteins (BMPs): extension of the two-kinase receptor model to the BMPs. Mol Cell Biol. 1995;15:3479-3486.
11. Brand T, MacLellan WR, Schneider MD. A dominant-negative receptor for type-β transforming growth factors created by deletion of the kinase domain. J Biol Chem. 1993;268:11500-11503.
12. Wieser R, Attisano L, Wrana JL, Massagué J. Signaling activity of transforming growth factor-β type-II receptors lacking specific domains in the cytoplasmic region. Mol Cell Biol. 1993;13: 7239-7247.
13. Chen RH, Ebner R, Derynck R. Inactivation of the type-II receptor reveals two receptor pathways for the diverse TGF-β activities. Science. 1993;260:1335-1338.
14. Hemmati-Brivanlou A, Melton DA. A truncated activin receptor inhibits mesoderm induction and formation of axial structures in Xenopus embryos. Nature. 1992;359:609-614.
15. Graff JM, Thies RS, Song JJ, Celeste AJ, Melton DA. Studies with a Xenopus BMP receptor suggest that ventral mesoderm-inducing signals override dorsal signals in vivo. Cell. 1994;79:169-179.
16. Letsou A, Arora K, Wrana JL, Simin K, Twombly V, Jamal J, Staehling-Hampton K, Hoffmann FM, Gelbart WM, Massagué J, O'Connor MB. Drosophila dpp signaling is mediated by the punt gene product: a dual ligand-binding type II receptor of the TGF β receptor family. Cell. 1995;80:899-908.
17. Okadome T, Yamashita H, Franzen P, Moren A, Heldin CH, Miyazono K. Distinct roles of the intracellular domains of transforming growth factor-β type I and type II receptors in signal transduction. J Biol Chem. 1994;269:30753-30756.
18. Carcamo J, Zentella A, Massague J. Disruption of transforming growth factor β signaling by a mutation that prevents transphosphorylation within the receptor complex. Mol Cell Biol. 1995;15: 1573-1581.
19. Wieser R, Wrana JL, Massague J. GS domain mutations that constitutively activate TβR-I, the downstream signaling component in the TGF-β receptor complex. EMBO J. 1995;14:2199-2208.
20. Wang TW, Donahoe PK, Zervos AS. Specific interaction of type I receptors of the TGF-β family with the immunophilin FKBP-12. Science. 1994;265:674-676.
21. Bhushan A, Lin HY, Lodish HF, Kintner CR. The transforming growth factor β type II receptor can replace the activin type II receptor in inducing mesoderm. Mol Cell Biol. 1994;14:4280-4285.
22. Cornell RA, Kimelman D. Activin-mediated mesoderm induction requires FGF. Development. 1994;120:452-462.
23. Klein PS, Melton DA. Induction of mesoderm in Xenopus laevis embryos by translation initiation factor 4E. Science. 1994;265: 803-806.
24. Abdellatif M, MacLellan WR, Schneider MD. p21 Ras as a governor of global gene expression. J Biol Chem. 1994;269: 15423-15426.
25. Sherr CJ, Roberts JM. Inhibitors of mammalian G(1) cyclin-dependent kinases. Genes Dev. 1995;9:1149-1163.
26. Kirshenbaum LA, Schneider MD. Adenovirus E1A represses cardiac gene transcription and reactivates DNA synthesis in ventricular myocytes, via alternative pocket protein- and p300-binding domains. J Biol Chem. 1995;270:7791-7794.
27. Reynisdóttir I, Polyak K, Iavarone A, Massagué J. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β. Genes Dev. 1995;9:1831-1845.
28. Schwarz JK, Bassing CH, Kovesdi I, Datto MB, Blazing M, George S, Wang XF, Nevins JR. Expression of the E2F1 transcription factor overcomes type β transforming growth factor-mediated growth suppression. Proc Natl Acad Sci U S A. 1995;92:483-487.
29. MacLellan WR, Lee TC, Schwartz RJ, Schneider MD. Transforming growth factor-β response elements of the skeletal α-actin gene: combinatorial action of serum response factor, YY1, and the SV40 enhancer-binding protein, TEF-1. J Biol Chem. 1994;269: 16754-16760.
30. 1-adrenergic induction of the skeletal alpha-actin promoter during cardiac myocyte hypertrophy: transcriptional enhancer factor-1 and protein kinase C as conserved transducers of the fetal program in cardiac growth. J Biol Chem. 1995;270:410-417.
31. Frasch M. Induction of visceral and cardiac mesoderm by ectodermal dpp in the early Drosophila embryo. Nature. 1995;374; 464-467.
32. Arora K, Dai H, Kazuko SG, Jamal J, O'Connor MB, Letsou A, Warrior R. The Drosophila schnurri gene acts in the dpp/TGF β signaling pathway and encodes a transcription factor homologous to the human MBP family. Cell. 1995;81:781-790.
33. Johansson BM, Wiles MV. Evidence for involvement of activin A and bone morphogenetic protein 4 in mammalian mesoderm and hematopoietic development. Mol Cell Biol. 1995;15:141-151.
34. Levin M, Johnson RL, Stern CD, Kuehn M, Tabin C. A molecular pathway determining left-right asymmetry in chick embryogenesis. Cell. 1995;82:803-814.
35. Letterio JJ, Geiser AG, Kulkarni AB, Roche NS, Sporn MB, Roberts AB. Maternal rescue of transforming growth factor-β 1 null mice. Science. 1994;264:1936-1938.